Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1997Antimicrobial Agents and ChemotherapyOpen Access

Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

View Full Paper
Ask AI
Bookmark
Share

Authors

Michael A. Pfaller
Michael A. PfallerUniversity of VermontSMS. A. MesserJMI LaboratoriesRJRonald N. JonesNorthwestern University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pfaller et al. (1997) studied this question.

synapsesocial.com/papers/6a896dd040fe6a3effcb083dhttps://doi.org/10.1128/aac.41.2.233
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis1996 · 96 citations
  2. 2In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts1997 · 83 citations
  3. 3Manual of Clinical Microbiology.1980 · 14,441 citations
  4. 4National Committee for Clinical Laboratory Standards1980 · 14,792 citations
  5. 5In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans1996 · 128 citations